Luke A. Jelen

2.1k total citations
23 papers, 691 citations indexed

About

Luke A. Jelen is a scholar working on Pharmacology, Biological Psychiatry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Luke A. Jelen has authored 23 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 10 papers in Biological Psychiatry and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Luke A. Jelen's work include Treatment of Major Depression (11 papers), Tryptophan and brain disorders (10 papers) and Psychedelics and Drug Studies (6 papers). Luke A. Jelen is often cited by papers focused on Treatment of Major Depression (11 papers), Tryptophan and brain disorders (10 papers) and Psychedelics and Drug Studies (6 papers). Luke A. Jelen collaborates with scholars based in United Kingdom, United States and Italy. Luke A. Jelen's co-authors include Allan H. Young, James Stone, James Rucker, Mitul A. Mehta, Matthew Butler, Sinéad King, Laith Alexander, Paul G. Mullins, David J. Lythgoe and Anthony J. Cleare and has published in prestigious journals such as Nature Medicine, Neuroscience & Biobehavioral Reviews and Psychological Medicine.

In The Last Decade

Luke A. Jelen

22 papers receiving 672 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luke A. Jelen United Kingdom 12 271 253 252 203 146 23 691
Natalie Hesselgrave United States 8 269 1.0× 329 1.3× 160 0.6× 138 0.7× 149 1.0× 8 621
Martha López-Canul Canada 11 181 0.7× 330 1.3× 282 1.1× 104 0.5× 81 0.6× 19 783
Luca Posa Canada 12 290 1.1× 401 1.6× 281 1.1× 78 0.4× 132 0.9× 23 834
Lily R. Aleksandrova Canada 9 149 0.5× 272 1.1× 249 1.0× 226 1.1× 54 0.4× 11 572
Collin Reiff United States 8 499 1.8× 195 0.8× 137 0.5× 73 0.4× 240 1.6× 11 653
Filip Tylš Czechia 12 403 1.5× 399 1.6× 238 0.9× 65 0.3× 214 1.5× 27 742
Adelaida Morte Spain 14 556 2.1× 281 1.1× 210 0.8× 45 0.2× 175 1.2× 27 1.1k
Jennifer Swainson Canada 12 130 0.5× 111 0.4× 374 1.5× 303 1.5× 33 0.2× 30 638
Lysia Demetriou United Kingdom 13 627 2.3× 438 1.7× 112 0.4× 74 0.4× 368 2.5× 20 961
Vincent Beliveau Austria 16 175 0.6× 324 1.3× 77 0.3× 54 0.3× 65 0.4× 39 828

Countries citing papers authored by Luke A. Jelen

Since Specialization
Citations

This map shows the geographic impact of Luke A. Jelen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke A. Jelen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke A. Jelen more than expected).

Fields of papers citing papers by Luke A. Jelen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luke A. Jelen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke A. Jelen. The network helps show where Luke A. Jelen may publish in the future.

Co-authorship network of co-authors of Luke A. Jelen

This figure shows the co-authorship network connecting the top 25 collaborators of Luke A. Jelen. A scholar is included among the top collaborators of Luke A. Jelen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luke A. Jelen. Luke A. Jelen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Daly, Owen, Luke A. Jelen, Thomas J. Reilly, et al.. (2025). Diazepam modulates hippocampal CA1 functional connectivity in people at clinical high-risk for psychosis. Psychological Medicine. 55. e230–e230.
2.
Jelen, Luke A., David J. Lythgoe, James Stone, Allan H. Young, & Mitul A. Mehta. (2025). Effect of naltrexone pretreatment on ketamine-induced glutamatergic activity and symptoms of depression: a randomized crossover study. Nature Medicine. 31(9). 2958–2966. 3 indexed citations
3.
Jelen, Luke A., et al.. (2024). Aticaprant: (a κ-opioid receptor antagonist) for major depressive disorder. Expert Opinion on Emerging Drugs. 29(3). 193–204. 4 indexed citations
4.
Jelen, Luke A., Rupert McShane, & Allan H. Young. (2024). Guidelines for ketamine use in clinical psychiatry practice. BJPsych Open. 10(3). e107–e107. 2 indexed citations
5.
Jelen, Luke A., Allan H. Young, & Mitul A. Mehta. (2023). Opioid Mechanisms and the Treatment of Depression. Current topics in behavioral neurosciences. 66. 67–99. 6 indexed citations
6.
Jelen, Luke A., et al.. (2023). A transdiagnostic systematic review and meta-analysis of ketamine’s anxiolytic effects. Journal of Psychopharmacology. 37(8). 764–774. 11 indexed citations
7.
Jelen, Luke A. & Allan H. Young. (2022). New antidepressants: New day or false dawn?. European Neuropsychopharmacology. 63. 1–3. 4 indexed citations
8.
Jelen, Luke A., Sinéad King, Alex Morris, et al.. (2022). Variants in the zinc transporter-3 encoding gene (SLC30A3) in schizophrenia and bipolar disorder: Effects on brain glutamate–A pilot study. Frontiers in Psychiatry. 13. 929306–929306. 3 indexed citations
9.
Butler, Matthew, Luke A. Jelen, & James Rucker. (2022). Expectancy in placebo-controlled trials of psychedelics: if so, so what?. Psychopharmacology. 239(10). 3047–3055. 56 indexed citations
10.
Jelen, Luke A., James Stone, Allan H. Young, & Mitul A. Mehta. (2022). The opioid system in depression. Neuroscience & Biobehavioral Reviews. 140. 104800–104800. 51 indexed citations
11.
Jelen, Luke A., David J. Lythgoe, Jade Jackson, et al.. (2021). Imaging Brain Glx Dynamics in Response to Pressure Pain Stimulation: A 1H-fMRS Study. Frontiers in Psychiatry. 12. 681419–681419. 3 indexed citations
12.
Alexander, Laith, Luke A. Jelen, Mitul A. Mehta, & Allan H. Young. (2021). The anterior cingulate cortex as a key locus of ketamine’s antidepressant action. Neuroscience & Biobehavioral Reviews. 127. 531–554. 49 indexed citations
13.
Stocking, Katie, et al.. (2021). A comparison of mdma-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis. European Psychiatry. 64(S1). S141–S142. 3 indexed citations
14.
Bird, Catherine, Luke A. Jelen, Gemma Knight, et al.. (2020). Historic psychedelic drug trials and the treatment of anxiety disorders. Depression and Anxiety. 37(12). 1261–1279. 24 indexed citations
15.
Juruena, Mário F., Luke A. Jelen, Allan H. Young, & Anthony J. Cleare. (2020). New Pharmacological Interventions in Bipolar Disorder. Current topics in behavioral neurosciences. 48. 303–324. 5 indexed citations
16.
Jelen, Luke A., Allan H. Young, & James Stone. (2020). Ketamine: A tale of two enantiomers. Journal of Psychopharmacology. 35(2). 109–123. 158 indexed citations
17.
Jelen, Luke A. & Allan H. Young. (2020). The Treatment of Bipolar Depression: Current Status and Future Perspectives. Current Behavioral Neuroscience Reports. 7(1). 1–14. 5 indexed citations
18.
King, Sinéad, Luke A. Jelen, Anthony J. Cleare, et al.. (2019). Inflammation, Glutamate, and Cognition in Bipolar Disorder Type II: A Proof of Concept Study. Frontiers in Psychiatry. 10. 66–66. 19 indexed citations
19.
20.
Jelen, Luke A., Sinéad King, Paul G. Mullins, & James Stone. (2018). Beyond static measures: A review of functional magnetic resonance spectroscopy and its potential to investigate dynamic glutamatergic abnormalities in schizophrenia. Journal of Psychopharmacology. 32(5). 497–508. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natalie Hesselgrave Breakdown of academic impact, for papers by Martha López-Canul Breakdown of academic impact, for papers by Luca Posa Breakdown of academic impact, for papers by Lily R. Aleksandrova Breakdown of academic impact, for papers by Collin Reiff Breakdown of academic impact, for papers by Filip Tylš Breakdown of academic impact, for papers by Adelaida Morte Breakdown of academic impact, for papers by Jennifer Swainson Breakdown of academic impact, for papers by Lysia Demetriou Breakdown of academic impact, for papers by Vincent Beliveau
Rankless by CCL
2026